LadRx Corp
LADXDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000799698
LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by LadRx Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for LadRx Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Caloz John Y | Chief Financial Officer | – | Jan 29, 2024 | 0 |
| Claiborne Cary J | Director | – | Jan 29, 2024 | 0 |
| Simpson Jennifer K. | Director | – | Jan 29, 2024 | 0 |
| Caldwell Joel K | Director | – | Jan 29, 2024 | 0 |
| Snowdy Stephen | Chief Executive Officer | – | Jan 29, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.